Royal Sense (544143)
Score breakdown: P/E: 3/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹139 |
| Market Cap | ₹68.11 Cr |
| P/E Ratio | 11.47 |
| ROCE | 35.18% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 70.59% |
| Debt/Equity | — |
| Sales Growth | 97.46% |
| 52-Week Range | ₹122.05 — ₹255.9 |
| Sector | Healthcare Equipment & Supplies |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
Let me examine Royal Sense the way I would examine any business: through the lens of durable economics, honest numbers, and a margin of safety. It is a small medical equipment supplier with a market cap of just ₹68 Cr. The immediate attraction is growth: sales up 97.46% and profits up 70.59%. At ₹139, the P/E is only 11.47, and the PEG ratio of 0.14 suggests the market is paying very little for that growth. That is interesting, but I do not buy a business simply because the screen looks cheap.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer